Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Royalty Pharma plc
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
July 22, 2026
Royalty Pharma declares third quarter 2026 dividend
July 17, 2026
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026
July 15, 2026
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 4, 2026
←
Previous Page
1
2